Affiliation:
1. CEB—Centre of Biological Engineering, University of Minho, 4750 Braga, Portugal
2. CIIMAR/CIMAR—Interdisciplinary Centre of Marine and Environmental Research and Department of Biology, Faculty of Sciences, University of Porto, 4169-007 Porto, Portugal
Abstract
Lichens are organisms constituted by a symbiotic relationship between a fungus (mycobiont) and a photoautotrophic partner (photobiont). Lichens produce several bioactive compounds; however, the biotechnological exploitation of this organism is hampered by its slow growth. To start studying the possibility of exploiting lichens as alternative sources of bioactive compounds, eighteen lichens were collected in the north of Portugal in order to isolate and study the bioactivity of their photobionts. It was possible to isolate and cultivate only eight photobionts. Three of them, LFR1, LFA2 and LCF3, belong to the Coelastrella genus, the other two (LFA1 and LCF1) belong to the Chlorella genus and for the remaining three photobionts, LFS1, LCA1 and LCR1, it was impossible to isolate their microalgae. These only grow in consortium with bacteria and/or cyanobacteria. All extracts showed antioxidant activity, mainly at a concentration of 10 mg.mL−1. LFS1, a consortium extract, showed the highest antioxidant power, as well as the highest concentration of phenolic compounds (5.16 ± 0.53 mg of gallic acid equivalents (GAE).g−1). The extracts under study did not show significant antibacterial activity against Escherichia coli, Listeria or Salmonella. The Coelastrella sp. and LFA1 extracts showed the highest hyaluronidase inhibition. The LFR1 extract at a concentration of 5 mg.mL−1 showed the highest anti-inflammatory activity (79.77 ± 7.66%). The extracts of Coelastrella sp. and LFA1 also showed greater antidiabetic activity, demonstrating the high inhibitory power of α-amylase and α-glucosidase. LFR1 at a concentration of 5 mg.mL−1, due to its selective cytotoxicity inhibiting the growth of cancer cells (Caco-2 cells), is a promising anticancer agent.
Funder
Luís Loureiro
Portuguese Foundation for Science and Technology (FCT) under the scope of the strategic
LABBELS–Associate Laboratory in Biotechnology, Bioengineering and Microelectromechnaical Systems
NORTE2020 Funds through the SUPPORT SYSTEM FOR SCIENTIFIC AND TECHNOLOGICAL RESEARCH-”STRUCTURED R & D & I PROJECTS”-HORIZON EUROPE
ALGAVALOR-Lisboa
Operational Programme for Competitiveness and Internationalization
Lisbon Portugal Regional Operational Programme
Algarve Regional Operational Programme
ERDF Funds through the Competitiveness factors Operational program—COMPETE—and by National Funds through the FCT under the project AgriFood XXI
FCT